Related Experiment Video
Updated: Jul 19, 2026
11:35
The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
Extensive validation study of the Parkinson's Disease Composite Scale
P Martinez-Martin1,2, F G Radicati3, C Rodriguez Blazquez1,2
1National Center of Epidemiology, Carlos III Institute of Health, Madrid, Spain.
European Journal of Neurology
|April 26, 2019
Summary
The Parkinson
Area of Science:
- Neurology
- Clinical Assessment Tools
- Parkinson's Disease Research
Background:
- Parkinson's disease (PD) management requires comprehensive assessment of motor and non-motor symptoms.
- Existing assessment tools may not adequately capture the full spectrum of PD in clinical settings.
- The Parkinson's Disease Composite Scale (PDCS) was developed to address this unmet need.
Purpose of the Study:
- To extensively evaluate the clinimetric properties of the PDCS.
- To assess the validity, reliability, and precision of the PDCS in a large international cohort.
- To confirm the PDCS's utility in real-world clinical practice.
Main Methods:
- A cross-sectional study involving 776 Parkinson's disease patients.
- Application of the PDCS alongside established scales: MDS-UPDRS and CISS-PD.
- Analysis of clinimetric attributes including reliability, validity, and factor structure.
Main Results:
- The PDCS demonstrated negligible floor/ceiling effects and identified three key factors: motor impairment/disability, non-motor symptoms, and tremor/therapy complications.
- High internal consistency (Cronbach's alpha 0.66-0.79) and excellent inter-rater reliability (kappa 0.79-0.98, ICC 0.95-0.99) were observed.
- Satisfactory convergent validity and significant differences in scores across Hoehn and Yahr stages confirmed PDCS sensitivity.
Conclusions:
- The PDCS is a feasible, acceptable, valid, reliable, and precise instrument for Parkinson's disease assessment.
- The scale enables quick and comprehensive evaluation of PD patients in clinical settings.
- Findings support the PDCS as a valuable tool for routine clinical use and research.
Related Concept Videos
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:22Self-Report Tests of Personality
Self-report inventories are objective personality assessments that use multiple-choice items or numbered scales, typically ranging from 1 (strongly disagree) to 5 (strongly agree). They are often called Likert scales after Rensis Likert. These inventories are widely used due to their ease of administration and cost-effectiveness. One of the most prominent examples is the Minnesota Multiphasic Personality Inventory (MMPI), initially developed in the 1940s to assess abnormal personality traits.
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...